Canada Issues Darzalex Recall Due To Complication Risks In Patients
Daratumumab, better known as Darzalex, is an intravenous medication that is produced by Janssen Biotech in order to treat a cancer known as multiple myeloma or Kahler’s disease. Kahler’s disease [...]